Duke-NUS
Singapore
Location status: Recruiting
NCT Number: NCT06817876
The study aims to develop a mobile-app (Care Buddy) which will be a one-stop integrated source of information and technology-based solutions for caregivers of people with dementia (PWDs). Study aims to bring caregivers into closer partnerships with the wider ecosystem (e.g., healthcare practitioners, community services, peer support, and care service providers) which will ultimately improve outcomes for both PWDs and their caregivers.
Interested in participating?
Request Info21 year–80 year
All sexes
Interventional
Not applicable
Singapore
Location status: Recruiting
This is a 5-year study with various stages: 1) proof-of-concept stage to design and develop the Care buddy intervention, 2) proof-of-value stage to assess the feasibility, acceptability and satisfaction with the Care buddy intervention among informal caregivers of PWDs, 3) test-bedding stage to assess the efficacy and cost-effectiveness of the Care buddy intervention versus usual care among informal caregivers of PWDs with help of a multi-centre 2-arm RCT and 4) deployment stage to scale up the intervention at multiple centres across Singapore, monitor its adoption and outcomes and assess any organizational and individual barriers to adoption.
By the end of the proposed five-year project, investigators aim to develop and evaluate the technology as well as achieve widespread adoption among caregivers of PWDs. Investigators want to enable easy access to information, provide decisional and social support, improve the reach and uptake of existing community service providers, and assist with coordination among multiple informal and professional caregivers through the journey of dementia caregiving and into the bereavement phase.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Care Buddy mobile intervention will be a one-stop solution for caregivers of dementia patients and help them in their care-giving journey by providing them solutions to manage behavioural problems, physical conditions of their loved one. The app will be multi-component and will provide tools for the caregiver to manage their stress and burden. It will provide information on dementia, list of service providers, information on grief, financial support. This app will provide a platform for all enrolled caregivers to chat with each other and provide social support.
Time frame: 1 year from data collection
Flourish - range - 8 - 56, high score represents a person with many psychological resources and strengths
Time frame: 1 year from data collection
Friendship scale - The score range is 0-24. A high score represents social connectedness and a score of "0" complete social isolation
Time frame: 1 year from data collection
The Dementia Knowledge Assessment Tool - range - 0-21. High score equals to higher knowledge of dementia.
Time frame: 1 year from data collection
Revised Memory & Behavior Problem checklist - range - 0-96 Higher score indicates increased impact.
Time frame: 1 year from data collection
Zarit Burden scale - range 0-88. 0 - 21 little or no burden, 21 - 40 mild to moderate burden, 41 - 60 moderate to severe burden, 61 - 88 severe burden >34 - clinically significant burden.
Time frame: 1 year from data collection
Perceived Stress Scale: Scoring: PSS scores are obtained by reversing responses (e.g., 0 = 4, 1 = 3, 2 = 2, 3 = 1 & 4 = 0) to the four positively stated items (items 4, 5, 7, & 8) and then summing across all scale items.
Time frame: 1 year from data collection
Health care costs, hospitalizations and emergency room visits for caregivers and PWDs will be obtained from patient billing data.
Contact information is provided by the study sponsor or research team.
Duke-NUS Graduate Medical School
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02014246
Brain Diseases, Central Nervous System Diseases
Baltimore, Maryland, United States
View Trial DetailsNCT07730957
Aberrant Motor Behavior in Dementia, Behavior
Amiens, France
View Trial DetailsNCT05552157
Alzheimer Disease, Alzheimers Disease
Birmingham, Alabama, United States
View Trial DetailsNCT06647498
Alzheimer Disease, Alzheimers Disease
Birmingham, Alabama, United States
View Trial Details